Related Experiment Video
Updated: Jul 9, 2025
Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated
Minu Treeza M1, Sanu Augustine1, Aparna Ann Mathew1
1Amrita School of Pharmacy, Amrita Institute of Medical Sciences & Research Centre, Amrita Vishwa Vidyapeetham, Kochi-682041, India.
Abstract:
Infection with SARS-CoV-2 is a growing concern to the global well-being of the public at present. Different amino acid mutations alter the biological and epidemiological characteristics, as well as immune resistance of SARS-CoV-2. The virus-induced pulmonary impairment and inflammatory cytokine storm are directly related to its clinical manifestations. But, the fundamental mechanisms of inflammatory responses are found to be the reason for the death of immune cells which render the host immune system failure. Apoptosis of immune cells is one of the most common forms of programmed cell death induced by the virus for its survival and virulence property. ORF3a, a SARS-CoV-2 accessory viral protein, induces apoptosis in host cells and suppress the defense mechanism. This suggests, inhibiting SARS-CoV-2 ORF3a protein is a good therapeutic strategy for the treatment in COVID-19 infection by promoting the host immune defense mechanism.
Insights
The SARS-CoV-2 virus causes cell death, weakening the immune system. Inhibiting the ORF3a protein may be a therapeutic strategy to boost immune defense against COVID-19.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection poses a significant global health threat.
- Viral mutations impact SARS-CoV-2 characteristics and immune evasion.
- Inflammatory responses, including cytokine storms and immune cell apoptosis, contribute to COVID-19 severity and mortality.
Purpose of the Study:
- To investigate the role of SARS-CoV-2 accessory protein ORF3a in inducing immune cell apoptosis.
- To explore the potential of targeting ORF3a as a therapeutic strategy for COVID-19.
Main Methods:
- Analysis of SARS-CoV-2 infection mechanisms.
- Investigation of viral protein functions, specifically ORF3a.
- Evaluation of apoptosis induction in host cells by ORF3a.
Main Results:
- SARS-CoV-2 infection leads to immune cell apoptosis, a programmed cell death mechanism.
- The viral accessory protein ORF3a is identified as an inducer of host cell apoptosis.
- ORF3a suppresses the host's immune defense mechanisms.
Conclusions:
- Immune cell apoptosis is a key factor in SARS-CoV-2 pathogenesis and host immune failure.
- Targeting and inhibiting the SARS-CoV-2 ORF3a protein presents a promising therapeutic avenue.
- Inhibiting ORF3a could enhance host immune defense, offering a potential treatment for COVID-19.
Related Concept Videos
02:28Leaky Scanning
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...